Congress

DC Report

First Opinion

Deadline looms to stop the Health Insurance Tax — but Congress has been there before

By Allyson Y. Schwartz

FDA Nominee Stephen Hahn

Politics

Senate confirms Stephen Hahn, oncologist and political newcomer, as FDA commissioner

By Nicholas Florko

advertisement

H.R. 3 press conference Pelosi

Politics

House passes major drug-pricing bill, a Democratic salvo in a showdown far from over

advertisement

Lab coat and stethoscope

First Opinion

Congress: Don’t eliminate funding for the diversity creating Health Career Opportunity Program

By LaShyra Nolen

HR 3 ad/Politico

Politics

It’s a bonanza: With drug pricing bill up for a vote, D.C. news outlets are drowning in advocacy ads

By Nicholas Florko

Pramila Jayapal

Politics

After a long fight, progressives secure small tweaks to Pelosi’s drug pricing package

By Nicholas Florko

Nancy Pelosi Dec. 6

Politics

Democrats’ drug pricing bill is a sneak peek at the party’s 2020 campaign message

advertisement

Trump in the Villages

Politics

With new trade deal, Trump deals a blow to drug makers

By Nicholas Florko

advertisement

Pelosi - October 2019

Politics

What’s real — and what’s illusion — in drug pricing legislation on Capitol Hill

By Nicholas Florko

HR 3

First Opinion

H.R. 3 is the wrong path to lower drug costs

By Mike Guerra

Rep. Greg Walden

Politics

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Sen. Elizabeth Warren

Pharmalot

Lawmakers ask HHS for greater oversight of patient assistance programs

By Ed Silverman

Grassley

Politics

Revamped, bipartisan Senate package takes aim at drug prices — and props up other health programs, too

By Nicholas Florko

Nancy Pelosi

Politics

More than 100 small biotech CEOs sound off against Pelosi’s signature drug pricing bill

By Nicholas Florko

Pharmalot

Pharmalittle: White House claims Dem pricing bill will yield 100 fewer drugs; trade deal may remove some biologic protections

By Ed Silverman

John Arnold

Health

How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill

Jessica Thomas

Pharmalot

Pharma execs tell researchers that multiple sclerosis drug pricing is based on competition, not R&D costs

By Ed Silverman

The Readout LOUD

Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

FDA Nominee Stephen Hahn

Politics

Stephen Hahn, Trump’s FDA nominee, pledges ‘bold action’ on vaping but sidesteps questions on flavor ban

Bipartisan medicine

First Opinion

Some bipartisan support for biosimilars is good. More would be better

By Juliana Reed

Politics

12 burning questions for Stephen Hahn, Trump’s pick to lead FDA

By Nicholas Florko

Bernie Sanders, Sen. Elizabeth Warren

Politics

Warren and Sanders: More scrutiny needed of commercial boards that decide whether to green-light clinical trials

By Rebecca Robbins

D.C. Insight IMAGE

Politics

Biotech venture capitalists form a lobbying coalition to join the drug pricing debate

By Nicholas Florko

Elizabeth Warren - BG Photo

Health

Elizabeth Warren’s health care evolution has earned her friends on the left, but foes in her home state

By Lev Facher — STAT and Liz Goodwin — Boston Globe

Cory Booker

First Opinion

Booker-Sanders-Harris drug affordability bureau could be brilliant

By Jessica Sagers and Peter Kolchinsky

Pharmalot

Pharmalittle: VCs warn Congress on drug-pricing bill; drugs look better than surgery or stents

By Elizabeth Cooney

Paul Tonko

Politics

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

Nancy Pelosi

Politics

In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill

By Nicholas Florko

Pharmalot

Pharmalittle: WHO to advance generic insulins; Trump wants more aggressive foreign pricing index

By Ed Silverman